日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study

Simlukafusp alfa (FAP-IL2v) 联合阿特珠单抗,加或不加贝伐珠单抗,用于治疗不可切除的转移性肾细胞癌:一项随机、开放标签的 Ib 期研究

Perez-Gracia, Jose Luis; Mellado, Begoña; Hansen, Aaron Richard; Alonso-Gordoa, Teresa; Gomez-Roca, Carlos; Løvendahl Eefsen, Rikke; Negrier, Sylvie; Suárez, Cristina; Lee, Jae-Lyun; Hussain, Arif; Pedrazzoli, Paolo; Moreno, Victor; Rodriguez-Vida, Alejo; Sosman, Jeffrey Alan; Waddell, Tom; Bedke, Jens; Park, Se Hoon; Sznol, Mario; Spychaj, Lukasz; Andersson, Emilia; Julien-Laferriere, Alice; Cheng, Wei-Yi; Watson, Carl; Silva, Ana Patricia; Heichinger, Christian; Staedler, Nicolas; Sleiman, Nassim; Dejardin, David; Boetsch, Christophe; Evers, Stefan; Vardar, Taner; Ardeshir-Tandon, Caroline; Dorado Pérez, Jorge; Charo, Jehad; Keshelava, Nino; Kraxner, Anton; Teichgräber, Volker; Powles, Thomas

florio HAEMO-A Digital Medical Device for Monitoring of Treatment, Symptoms and Physical Activities for People Living With Haemophilia

florio HAEMO-A 是一款用于监测血友病患者治疗、症状和身体活动的数字医疗设备

Königs, Christoph; Astermark, Jan; Blatny, Jan; O Hara, Jamie; Iorio, Allfonso; Negrier, Claude; Peyvandi, Flora; Steinitz, Katharina; Reininger, Armin J; Bonanad, Santiago

Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial

阿维鲁单抗联合阿昔替尼对比舒尼替尼作为晚期肾细胞癌患者一线治疗方案:III期JAVELIN Renal 101试验的最终分析

Choueiri, T K; Penkov, K; Uemura, H; Campbell, M T; Pal, S; Kollmannsberger, C; Lee, J L; Venugopal, B; van den Eertwegh, A J M; Negrier, S; Gurney, H; Albiges, L; Berger, R; Haanen, J B A G; Oyervides Juárez, V; Rini, B I; Larkin, J; Nolè, F; Schmidinger, M; Atkins, M B; Tomita, Y; Ellers-Lenz, B; Hoffman, J; Sandner, R; Wang, J; di Pietro, A; Motzer, R J

Cost-effectiveness of nivolumab compared with surveillance for adjuvant treatment of muscle-invasive urothelial carcinoma at high risk of recurrence in France

在法国,对于复发风险高的肌层浸润性尿路上皮癌患者,使用纳武利尤单抗进行辅助治疗与监测相比的成本效益分析

Negrier, Sylvie; Bonastre, Julia; Colrat, Florian; Teitsson, Siguroli; Knight, Christopher; Ni, Lei; Chevalier, Julie; Branchoux, Sébastien; Rouprêt, Morgan

Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial

Fitusiran 预防治疗在既往接受过 BPA/CFC 预防治疗的 A 型或 B 型血友病患者中的应用:ATLAS-PPX 试验

Kenet, Gili; Nolan, Beatrice; Zulfikar, Bulent; Antmen, Bulent; Kampmann, Peter; Matsushita, Tadashi; You, Chur-Woo; Vilchevska, Kateryna; Bagot, Catherine N; Sharif, Azizan; Peyvandi, Flora; Young, Guy; Negrier, Claude; Chi, Jiarui; Kittner, Barbara; Sussebach, Christian; Shammas, Fadi; Mei, Baisong; Andersson, Shauna; Kavakli, Kaan

Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma

肺免疫预后指数(LIPI)作为转移性肾细胞癌预后生物标志物的验证

Carril-Ajuria, Lucia; Lavaud, Pernelle; Dalban, Cecile; Negrier, Sylvie; Gravis, Gwénaëlle; Motzer, Robert J; Chevreau, Christine; Tannir, Nizar M; Oudard, Stéphane; McDermott, David F; Laguerre, Brigitte; Hammers, Hans J; Barthelemy, Philippe; Plimack, Elizabeth R; Borchiellini, Delphine; Gross-Goupil, Marine; Jiang, Ruiyun; Lee, Chung-Wei; de Silva, Heshani; Rini, Brian I; Escudier, Bernard; Albigès, Laurence

Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia

针对成年男性血友病患者体内AAV抗体及其相关适应性免疫反应的流行情况的多中心评估和纵向研究

Pabinger, Ingrid; Ayash-Rashkovsky, Mila; Escobar, Miguel; Konkle, Barbara A; Mingot-Castellano, María Eva; Mullins, Eric S; Negrier, Claude; Pan, Luying; Rajavel, Kavitha; Yan, Brian; Chapin, John

Primary mitochondrial disorders and mimics: Insights from a large French cohort

原发性线粒体疾病及其类似疾病:来自法国大型队列研究的启示

Rouzier, Cécile; Pion, Emmanuelle; Chaussenot, Annabelle; Bris, Céline; Ait-El-Mkadem Saadi, Samira; Desquiret-Dumas, Valérie; Gueguen, Naïg; Fragaki, Konstantina; Amati-Bonneau, Patrizia; Barcia, Giulia; Gaignard, Pauline; Steffann, Julie; Pennisi, Alessandra; Bonnefont, Jean-Paul; Lebigot, Elise; Bannwarth, Sylvie; Francou, Bruno; Rucheton, Benoit; Sternberg, Damien; Martin-Negrier, Marie-Laure; Trimouille, Aurélien; Hardy, Gaëlle; Allouche, Stéphane; Acquaviva-Bourdain, Cécile; Pagan, Cécile; Lebre, Anne-Sophie; Reynier, Pascal; Cossee, Mireille; Attarian, Shahram; Paquis-Flucklinger, Véronique; Procaccio, Vincent

S303: A PHASE 3 STUDY (ATLAS-PPX) TO EVALUATE EFFICACY AND SAFETY OF FITUSIRAN IN PEOPLE WITH HAEMOPHILIA A OR B WHO HAVE SWITCHED FROM PRIOR CLOTTING FACTOR CONCENTRATE OR BYPASSING AGENT PROPHYLAXIS

S303:一项评估 Fitusiran 对既往接受过凝血因子浓缩物或旁路制剂预防治疗的 A 型或 B 型血友病患者的疗效和安全性的 3 期研究 (ATLAS-PPX)

Frampton, James E; Kenet, Gili; Nolan, Beatrice; Zulfikar, Bulent; Antmen, Bulent; Kampmann, Peter; Matsushita, Tadashi; You, Chur-Woo; Vilchevska, Kateryna; Bag, Catherine N; Sharif, Azizan; Peyvandi, Flora; Young, Guy; Negrier, Claude; Sussebach, Christian; Shammas, Fadi; Andersson, Shauna; Mei, Baisong; Kavakli, Kaan

Perilipin 2-positive mononuclear phagocytes accumulate in the diabetic retina and promote PPARγ-dependent vasodegeneration

糖尿病视网膜中,表达Perilipin 2的单核吞噬细胞聚集,并促进PPARγ依赖性血管退化。

Blot, Guillaume; Karadayi, Rémi; Przegralek, Lauriane; Sartoris, Thérèse-Marie; Charles-Messance, Hugo; Augustin, Sébastien; Negrier, Pierre; Blond, Frédéric; Muñiz-Ruvalcaba, Frida Paulina; Rivera-de la Parra, David; Vignaud, Lucile; Couturier, Aude; Sahel, José-Alain; Acar, Niyazi; Jimenez-Corona, Aida; Delarasse, Cécile; Garfias, Yonathan; Sennlaub, Florian; Guillonneau, Xavier